CSTM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Constellium SE (CSTM) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company's fundamentals and analyst sentiment are positive, the lack of immediate trading signals, neutral technical indicators, and the absence of recent news catalysts suggest waiting for a better entry point.
The technical indicators are mixed. The MACD is below 0 and negatively contracting, suggesting bearish momentum. RSI is neutral at 65.305, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near a resistance level (R1: 26.74), which could limit short-term upside potential.
Hedge funds are significantly increasing their positions, with a 128.16% increase in buying over the last quarter.
Analysts have raised price targets following a strong Q4 earnings report, with targets ranging from $28 to $
Financial performance in Q4 2025 showed significant EPS growth (+113.16% YoY) and improved gross margin (+32.37% YoY).
No recent news or event-driven catalysts to drive immediate price action.
Stock trend analysis suggests a potential decline in the short term (-1.62% in the next day, -2.42% in the next week, -4.52% in the next month).
Insiders are neutral, with no significant trading activity.
In Q4 2025, Constellium reported flat revenue growth ($2.201 billion, 0.00% YoY) but strong improvements in profitability metrics. Net income increased to $112 million (0.00% YoY), EPS rose to $0.81 (+113.16% YoY), and gross margin improved to 11.86% (+32.37% YoY).
Analysts are bullish on the stock, with multiple firms raising price targets after a strong Q4 earnings report. BMO Capital raised the target to $30, JPMorgan to $29, and Deutsche Bank to $28, all maintaining positive ratings (Outperform, Overweight, and Buy).
